Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


08.03.2021

1 Ann Oncol
3 Ann Surg Oncol
5 Ann Thorac Surg
1 Arch Pathol Lab Med
1 BMC Cancer
3 Cancer Res
2 Cancer Sci
1 Carcinogenesis
2 Chest
2 Clin Lung Cancer
1 Clin Nucl Med
1 Eur J Cancer
2 Eur J Cardiothorac Surg
1 Eur Respir J
2 Int J Radiat Oncol Biol Phys
5 J Clin Oncol
4 J Surg Oncol
3 J Thorac Oncol
1 Lancet
4 Lancet Oncol
4 Lung Cancer
5 Oncol Rep
1 Oncologist
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Oncol

  1. SZNOL M, Melero I
    Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy.
    Ann Oncol. 2021;32:295-297.
    PubMed        


    Ann Surg Oncol

  2. ZENG Q, Li J, Tan F, Sun N, et al
    Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Mar 2. pii: 10.1245/s10434-020-09552.
    PubMed         Abstract available

  3. SHIGEFUKU S, Shimada Y, Hagiwara M, Kakihana M, et al
    Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:148-156.
    PubMed         Abstract available

  4. LEINWAND JC, Kluger MD
    ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
    Ann Surg Oncol. 2020;27.
    PubMed        


    Ann Thorac Surg

  5. YAMAMICHI T, Ichinose J, Iwamoto N, Omura K, et al
    Correlation between smoking status and short-term outcome of thoracoscopic surgery for lung cancer.
    Ann Thorac Surg. 2021 Mar 2. pii: S0003-4975(21)00350.
    PubMed         Abstract available

  6. GAO W, Yang XL, Hu JC, Gu H, et al
    Continuous serratus anterior plane block improved early pulmonary function after lung cancer surgery.
    Ann Thorac Surg. 2021 Mar 2. pii: S0003-4975(21)00362.
    PubMed         Abstract available

  7. MUSLIM Z, Baig MZ, Weber JF, Connery CP, et al
    Travelling to a High-volume Center Confers Improved Survival in Stage I Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2021 Mar 1. pii: S0003-4975(21)00347.
    PubMed         Abstract available

  8. BERTOLACCINI L, Sedda G, Spaggiari L
    Paying Another Tribute to the COVID-19 Pandemic: The Decrease of Early Lung Cancers.
    Ann Thorac Surg. 2021;111:745-746.
    PubMed        

  9. TESTORI A, Perroni G, Voulaz E, Crepaldi A, et al
    Pulmonary Lobectomy After COVID-19.
    Ann Thorac Surg. 2021;111:e181-e182.
    PubMed         Abstract available


    Arch Pathol Lab Med

  10. TERRA SBSP, Roden AC, Aubry MC, Yi ESJ, et al
    Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.
    Arch Pathol Lab Med. 2021;145:208-213.
    PubMed         Abstract available


    BMC Cancer

  11. MINEGISHI Y, Yamaguchi O, Sugawara S, Kuyama S, et al
    A phase II study of first-line afatinib for patients aged >/=75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
    BMC Cancer. 2021;21:208.
    PubMed         Abstract available


    Cancer Res

  12. WANG X, Ricciuti B, Nguyen T, Li X, et al
    Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer.
    Cancer Res. 2021 Mar 2. pii: 0008-5472.CAN-20-3991.
    PubMed         Abstract available

  13. SHANI O, Vorobyov T, Monteran L, Lavie D, et al
    Fibroblast-derived IL-33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type-2 immunity.
    Cancer Res. 2020 Oct 6. pii: 0008-5472.CAN-20-2116.
    PubMed         Abstract available

  14. GARG R, Cooke M, Benavides F, Abba MC, et al
    PKCepsilon Is Required for KRAS-Driven Lung Tumorigenesis.
    Cancer Res. 2020;80:5166-5173.
    PubMed         Abstract available


    Cancer Sci

  15. HOU Z, Wang Y, Xia N, Lv T, et al
    Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR-497-5p/mTOR.
    Cancer Sci. 2021;112:275-286.
    PubMed         Abstract available

  16. KOSIBATY Z, Murata Y, Minami Y, Noguchi M, et al
    ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signaling.
    Cancer Sci. 2021;112:703-714.
    PubMed         Abstract available


    Carcinogenesis

  17. JIA G, Wen W, Massion PP, Shu XO, et al
    Incorporating Both Genetic and Tobacco Smoking Data to Identify High-Risk Smokers for Lung Cancer Screening.
    Carcinogenesis. 2021 Feb 26. pii: 6153462. doi: 10.1093.
    PubMed         Abstract available


    Chest

  18. TAJARERNMUANG P, Ofiara L, Beaudoin S, Wang H, et al
    Real-world outcomes of patients with advanced non-small cell lung cancer treated with anti-PD1 therapy on the basis of PD-L1 Results in EBUS-TBNA vs. histological specimens.
    Chest. 2021 Mar 3. pii: S0012-3692(21)00453-0. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  19. TURNER J, Pond GR, Tremblay A, Johnston M, et al
    Risk Perception Among a Lung Cancer Screening Population.
    Chest. 2021 Mar 2. pii: S0012-3692(21)00450-5. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available


    Clin Lung Cancer

  20. GREGORC V, Mazzarella L, Lazzari C, Graziano P, et al
    Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2021 Feb 25. pii: S1525-7304(20)30350.
    PubMed         Abstract available

  21. KIRKLAND RS, Kole AJ, Batra H, Boggs DH, et al
    Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis.
    Clin Lung Cancer. 2021 Feb 3. pii: S1525-7304(21)00019.
    PubMed         Abstract available


    Clin Nucl Med

  22. WU J, Liu H, Ou L, Jiang G, et al
    FAPI Uptake in a Vertebral Body Fracture in a Patient With Lung Cancer: A FAPI Imaging Pitfall.
    Clin Nucl Med. 2021 Mar 4. pii: 00003072-900000000-96183.
    PubMed         Abstract available


    Eur J Cancer

  23. SCHOTTEN LM, Darwiche K, Seweryn M, Yildiz V, et al
    DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients.
    Eur J Cancer. 2021;147:142-150.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  24. PARK S, Kim HJ, Park IK, Kim YT, et al
    Stereotactic ablative radiotherapy versus surgery in older patients with stage I lung cancer.
    Eur J Cardiothorac Surg. 2021 Feb 28. pii: 6154725. doi: 10.1093.
    PubMed         Abstract available

  25. ROMERO ROMAN A, Campo-Canaveral de la Cruz JL, Macia I, Escobar Campuzano I, et al
    Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021 Mar 1. pii: 6154485. doi: 10.1093.
    PubMed         Abstract available


    Eur Respir J

  26. KRISTOF AS
    Novel rare genetic variants in idiopathic pulmonary fibrosis.
    Eur Respir J. 2020;56.
    PubMed        


    Int J Radiat Oncol Biol Phys

  27. LEE SH, Kao GD, Feigenberg SJ, Dorsey JF, et al
    Multi-block Discriminant Analysis of Integrative (18)F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 1. pii: S0360-3016(21)00208.
    PubMed         Abstract available

  28. ARRIETA O, Maldonado F, Turcott JG, Zatarain-Barron ZL, et al
    Prophylactic Cranial Irradiation reduces brain metastases and improves overall survival in high-risk metastatic non-small cell lung cancer patients: a randomized phase II study (PRoT-BM trial).
    Int J Radiat Oncol Biol Phys. 2021 Feb 25. pii: S0360-3016(21)00225.
    PubMed         Abstract available


    J Clin Oncol

  29. LAU YM, Mok TSK
    The More, The Better?
    J Clin Oncol. 2020;38:3581-3583.
    PubMed        

  30. OSAROGIAGBON RU
    Volume-Based Care Regionalization: Pitfalls and Challenges.
    J Clin Oncol. 2020;38:3465-3467.
    PubMed        

  31. DERKS JL, Speel EM, Dingemans AC
    Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?
    J Clin Oncol. 2021 Mar 4:JCO2003598. doi: 10.1200/JCO.20.03598.
    PubMed        

  32. DZIADZIUSZKO R, Krebs MG, De Braud F, Siena S, et al
    Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2021 Mar 1:JCO2003025. doi: 10.1200/JCO.20.03025.
    PubMed         Abstract available

  33. GARASSINO MC, Besse B, Torri V
    To Continue or Not to Continue? That Is the Question.
    J Clin Oncol. 2020;38:3830-3832.
    PubMed        


    J Surg Oncol

  34. OZTURK A, Sener MU, Yilmaz A
    Bronchoscopic procedures during COVID-19 pandemic: Experiences in Turkey.
    J Surg Oncol. 2020;122:1020-1026.
    PubMed         Abstract available

  35. CHEN J, Gu C, Chen X, Dai C, et al
    Clinicopathological and prognostic analyses of 86 resected pulmonary lymphoepithelioma-like carcinomas.
    J Surg Oncol. 2021;123:544-552.
    PubMed         Abstract available

  36. BERTOGLIO P, Querzoli G, Ventura L, Aprile V, et al
    Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
    J Surg Oncol. 2021;123:560-569.
    PubMed         Abstract available

  37. ZHOU C, Wang Y, Qian G, Li H, et al
    Clinical significance of indeterminate pulmonary nodules on the survival of 364 patients with nonmetastatic, high-grade, localized osteosarcoma: A 12-year retrospective cohort study.
    J Surg Oncol. 2021;123:587-595.
    PubMed         Abstract available


    J Thorac Oncol

  38. MALHOTRA J, Nikolinakos P, Leal T, Lehman J, et al
    A Phase I/II Study of Rovalpituzumab Tesirine in Combination With Nivolumab +/- Ipilimumab in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer.
    J Thorac Oncol. 2021 Feb 27. pii: S1556-0864(21)01745.
    PubMed         Abstract available

  39. HENDRIKS LEL, Dingemans AC, De Ruysscher DKM, Aarts MJ, et al
    Lung Cancer in the Netherlands.
    J Thorac Oncol. 2021;16:355-365.
    PubMed        

  40. MINO-KENUDSON M, Le Stang N, Daigneault JB, Nicholson AG, et al
    IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2021 Mar 1. pii: S1556-0864(21)01732.
    PubMed         Abstract available


    Lancet

  41. CERESOLI GL, Pasello G
    Immune checkpoint inhibitors in mesothelioma: a turning point.
    Lancet. 2021;397:348-349.
    PubMed        


    Lancet Oncol

  42. SENAN S
    The elusive pursuit of progress in limited stage small-cell lung cancer.
    Lancet Oncol. 2021;22:290-291.
    PubMed        

  43. GRONBERG BH, Killingberg KT, Flotten O, Brustugun OT, et al
    High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
    Lancet Oncol. 2021;22:321-331.
    PubMed         Abstract available

  44. HORITA N, Katakura S, Takeshi K
    Combination treatment options for small-cell lung cancer.
    Lancet Oncol. 2021;22:e83.
    PubMed        

  45. GOLDMAN JW, Paz-Ares L
    Combination treatment options for small-cell lung cancer - Authors' reply.
    Lancet Oncol. 2021;22:e84.
    PubMed        


    Lung Cancer

  46. WONG SK, Alex D, Bosdet I, Hughesman C, et al
    MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy.
    Lung Cancer. 2021;154:142-145.
    PubMed         Abstract available

  47. KOK PS, Lee K, Lord S, Yang JC, et al
    Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis.
    Lung Cancer. 2021;154:113-117.
    PubMed         Abstract available

  48. FOURDRAIN A, Epailly J, Blanchard C, Georges O, et al
    Lymphatic drainage of lung cancer follows an intersegmental pathway within the visceral pleura.
    Lung Cancer. 2021;154:118-123.
    PubMed         Abstract available

  49. CHEN X, Muhammad KG, Madeeha C, Fu W, et al
    Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Lung Cancer. 2021 Feb 14. pii: S0169-5002(21)00065.
    PubMed         Abstract available


    Oncol Rep

  50. HU Y, Cui J, Jin L, Su Y, et al
    LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression.
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available

  51. YANG XG, Li YY, Zhao DX, Cui W, et al
    Repurposing of a monoamine oxidase A inhibitorheptamethine carbocyanine dye conjugate for paclitaxelresistant nonsmall cell lung cancer.
    Oncol Rep. 2021;45:1306-1314.
    PubMed         Abstract available

  52. LING B, Wei P, Xiao J, Cen B, et al
    Nucleolar and spindleassociated protein 1 promotes nonsmall cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Oncol Rep. 2021;45:1044-1058.
    PubMed         Abstract available

  53. GU X, Zhang J, Shi Y, Shen H, et al
    ESM1/HIF1alpha pathway modulates chronic intermittent hypoxiainduced nonsmallcell lung cancer proliferation, stemness and epithelialmesenchymal transition.
    Oncol Rep. 2021;45:1226-1234.
    PubMed         Abstract available

  54. LI S, Liu Y, Qiu G, Luo Y, et al
    Emerging roles of circular RNAs in nonsmall cell lung cancer (Review).
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available


    Oncologist

  55. FRASS M, Lechleitner P, Grundling C, Pirker C, et al
    Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study.
    Oncologist. 2021;26:e523.
    PubMed        


    PLoS One

  56. YOU JHS, Cho WCS, Ming WK, Li YC, et al
    EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong - A cost-effectiveness analysis.
    PLoS One. 2021;16:e0247860.
    PubMed         Abstract available

  57. UCHIDA Y, Tsugawa T, Tanaka-Mizuno S, Noma K, et al
    Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.
    PLoS One. 2020;15:e0244143.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: